Results 191 to 200 of about 19,507 (228)

Prescriber profile and postmarketing surveillance

Lancet, The, 1993
Gary Pearce
exaly   +2 more sources

Postmarketing Surveys

JCR: Journal of Clinical Rheumatology, 2002
openaire   +1 more source

Concerns with postmarketing surveillance

American Journal of Health-System Pharmacy, 1984
M J, Norvell, R J, Anderson
openaire   +2 more sources

Risk of hypertension in erenumab‐treated patients with migraine: Analyses of clinical trial and postmarketing data

Headache, 2021
David W Dodick, Jessica Ailani
exaly  

Postmarketing Research

2008
Stephen P. Glasser, Elizabeth Delzell, Maribel Salas   +2 more
openaire   +1 more source

Postmarketing Safety Surveillance

Pharmaceutical Medicine, 2010
Upasana Prabhakar, Brian Edwards
openaire   +1 more source

Postmarket Vaccine Safety

2023
Y. Tony Yang, Dorit R. Reiss
openaire   +1 more source

Postmarketing surveillance--some ethical considerations.

The Journal of rheumatology. Supplement, 1989
While postmarketing surveillance presents many of the ethical problems characteristic of research involving human subjects, this article focuses on some of the more frequently encountered issues: It is necessary to distinguish research from practice because ethical justification for these two classes of activity differs in important respects.
openaire   +2 more sources

ICD Leads and Postmarketing Surveillance

New England Journal of Medicine, 2012
Adam J Mead
exaly  

Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis

Modern Rheumatology, 2011
Masayoshi Harigai, Naoki Ishiguro, Tsutomu Takeuchi   +2 more
exaly